Dow Up 0.07% Nasdaq Up 0.17%

Celgene Corporation (CELG)

-NMS
95.30 Up 0.33(0.35%) 12:02PM EDT - Nasdaq Real Time Price
Prev Close:94.97
Open:95.58
Bid:95.14 x 300
Ask:95.16 x 1000
1y Target Est:104.48
Beta:1.5
Next Earnings Date:23-Oct-14CELG Earnings announcement
Day's Range:94.55 - 96.85
52wk Range:66.85 - 96.85
Volume:4,266,841
Avg Vol (3m):4,519,210
Market Cap:76.19B
P/E (ttm):55.09
EPS (ttm):1.73
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
CELGUp 0.35%76.19B
JNJUp 1.07%286.06B

Key Statistics

Forward P/E (1 yr):19.50
P/S (ttm):10.80
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :3.67
Quarterly EPS Est (Sep-14) :0.95
Mean Recommendation*:1.8
PEG Ratio (5 yr expected):0.98

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Celgene Corporation, a biopharmaceutical company, discovers, develops, and commercializes therapies to treat cancer and immune-inflammatory related diseases in the United States and internationally. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback